Folate levels in hepatocellular carcinoma patients with portal vein thrombosis

BMC Gastroenterology

Table 4 Clinical features of the HCC patients

	Serum folate				p value	Signif	Odds-ratio	95% CI O.R.
	≤ 5.9 mm/l (69 pt)		> 5.9 mm/l (69 pt)
	N	%	N	%
PVT	44	63.77	34	49.28	0.1219	ns	1.812	0.9335 to 3.584
HCC stage I	16	23.19	20	28.99	0.5612	ns	0.7396	0.3337 to 1.573
HCC stage II	18	26.09	23	33.33	0.4564	ns	0.7059	0.3412 to 1.519
HCC stage III	20	28.99	21	30.43	> 0.9999	ns	0.9329	0.4610 to 1.876
HCC stage IV	15	21.74	5	7.25	0.0276	*	3.556	1.265 to 9.289
Clip Score 0–2	31	44.93	28	40.58	0.7309	ns	1.195	0.6229 to 2.310
Clip Score 3–6	38	55.07	41	59.42	0.7309	ns	0.8371	0.4329 to 1.605
Cirrhosis	25	36.23	33	47.83	0.2272	ns	0.6198	0.3139 to 1.194
< 50 mm	25	36.23	33	47.83	0.2272	ns	0.6198	0.3139 to 1.194
> 50 mm	44	63.77	36	52.17	0.2272	ns	1.613	0.8373 to 3.185
Tumour Invasion	26	37.68	32	46.38	0.3886	ns	0.6991	0.3570 to 1.345
Vascular Invasion	29	42.03	31	44.93	0.8637	ns	0.8887	0.4619 to 1.701
Extra-hepatic MTS	44	63.77	29	42.03	0.0166	*	2.428	1.190 to 4.875

PVT, portal vein thrombosis; HCC, hepatocellular carcinoma; Mtd, max tumour diameter
Summary:*< 0.05; **< 0.005; ***< 0.001; ****< 0.0001

ISSN: 1471-230X